MOTS-c, as a mitochondrial-derived peptide, offers a unique approach to enhancing cellular energy, improving insulin sensitivity, and counteracting age-related metabolic decline by optimizing foundational cellular processes, particularly through AMPK activation and mitochondrial function
Magna A, Polisena N, Polisena L, Bagnato C, Pacella E, Carnevale R, et al
The first part of the study began by randomly dividing the test subjects in four groups including: wild type, APP/PS1, APP/PS1 + Dihexa administered at a dose of 1.44 mg/kg, and APP/PS1 + Dihexa administered at a dose of 2.88 mg/kg [1]
Hers has become one of the largest providers of compounded semaglutide in the country